The effective prevention of Streptococcus pneumoniae infection has a renewed priority in an
era in which the emergence of antibacterial-resistant strains has the potential to further …

The burden of pneumococcal disease among elderly people is not widely known. In most
countries, the annual incidence of invasive pneumococcal disease in elderly people is most …

PURPOSE: To study the efficacy of pneumococcal capsular polysaccharide vaccine among
the elderly by use of a population-based intervention in one township, Varkaus, Eastern …

During the 20 years following its licensure, pneumococcal vaccine has not been widely
used. Although the vaccine was shown to be efficacious in South African gold miners …

Streptococcus pneumoniae causes considerable morbidity and mortality in the elderly.
There are three established approaches to pneumococcal vaccination: polysaccharide …

Streptococcus pneumoniae remains a major cause of morbidity and mortality throughout the
world. To date, after the introduction of routine childhood immunization, elderly people (ie …

As individuals advance in age, the risk of infection, bacteremia, and mortality caused by
Streptococcus pneumoniae rises. Retrospective data demonstrate that the licensed …

Pneumococcal polysaccharide vaccine has been licensed for use in the United States for>
30 years, and two-thirds of the elderly population in the United States have received this …

Pneumococcal disease in the elderly is a major concern emphasizing the need for
prevention. The review focuses on a literature-based analysis of the efficacy (“does the …

Vaccination remains the primary preventive strategy in the elderly against Streptococcus
pneumoniae and influenza infections. The effectiveness of this strategy in preventing …